endometrium during the menstrual cycle and the effect of medical therapy. Fertility and Sterility 51:409–414, 1989.

Liu, J.H., and Yen, S.S.C. Induction of midcycle gonadotropin surge by ovarian steroid in women: A critical evaluation. Journal of Clinical Endocrinology and Metabolism 57:797–802, 1983.

Liu, J.H., Garzo, G., Morris, S., et al. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU 486. Journal of Clinical Endocrinology and Metabolism 65:1135–1140, 1987.

Lumsden, M.A., West, C.P., Hawkins, R.A., et al. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630). Journal of Endocrinology 121:389–396, 1989.

Luukkainen, T., Heikinheimo, O., Haukkamaa, M., et al. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. Fertility and Sterility 49:961–963, 1988.

Matta, W.H., Shaw, R.W., Hesp, R., et al. Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women. Clinical Endocrinology 29:45–51, 1988a.

Matta, W.H., Stabile, I., Shaw, R.W., et al. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist buserelin. Fertility and Sterility 49:1083–1085, 1988b.

Metzger, D.A., Szpak, C.A., and Haney, A.F. Histologic features associated with hormonal responsiveness of ectopic endometrium. Fertility and Sterility 59:83, 1993.

Neulen, J., Williams, R.F., Hodgen, G.D., et al. RU 486 (mifepristone): Induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. Journal of Clinical Endocrinology and Metabolism 71:1074–1075, 1990.

Perl, V., Marquez, J., Schally, A.V., et al. Treatment of leiomyomata uteri with D-Trp6 luteinizing hormone-releasing hormone. Fertility and Sterility 48:383–389, 1987.

Rein, M.S., Friedman, A.J., Stuart, J.M., et al. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertility and Sterility 53:1018, 1990.

Roseff, S.R., Kettel, L.M., Rivier, J., et al. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women. Fertility and Sterility 54:805, 1990.

Rummon, I.S., Radwanska, E., Ali, A., et al. Bone mineral density in women with endometriosis and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol. Fertility and Sterility 49:792–796, 1988.

Schaison, G., George M., Lestrat, N., et al. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women. Journal of Clinical Endocrinology and Metabolism 61:484–489, 1985.

Schlaff, W.D., Zerhouni, E.A., Huth, J.A., et al. A placebo-controlled trial of a depot GnRH analogue (leuprolide) in the treatment of uterine leiomyomata. Obstetrics and Gynecology 74:857–862, 1989.

Shaw, R.W. Treatment of Endometriosis. Lancet 340:1267, 1992.

Weigel, N.L., Beck, C.A., Estes, P.A., et al. Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Molecular Endocrinology 6:1585–1597, 1992.

West, C.P., Lunsden, M.A., Lawson, S., et al. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): A LHRH agonist administered as a monthly subcutaneous depot. Fertility and Sterility 48:45–51, 1987.

Wolf, J.P., Hsiu, J.F., Anderson, T.L., et al. Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and proliferative action of estradiol on endometrium in castrate monkeys. Fertility and Sterility 52:1055–1060, 1989.